Top Medical Apps Performance on Android in the US: Q4 2024

In the fourth quarter of 2024, the top medical apps on the Android platform in the United States showcased diverse performance trends. Here’s a closer look at how these applications fared in terms of downloads, revenue, and active user engagement.

Drug Checker App from Epocrates, Inc. saw a consistent weekly revenue, peaking at around $28.3K in late October. Downloads spiked to approximately 1.1K around the same period. The app maintained a strong active user base, reaching a peak of about 42.9K in early December.

Sanford Guide Antimicrobial experienced varied revenue trends, with a notable high of $9.5K in early November. Downloads were sporadic, with a few spikes, such as 73 downloads in the week of October 21. Active users slightly decreased over the quarter, ending at approximately 298.

Davis's Drug Guide showed a decline in revenue, starting from about $8.2K in mid-October down to $1.7K by the end of December. Downloads also decreased, from 276 in mid-October to 146 by the end of the year.

Migraine Buddy: Track Headache from Aptar Digital Health had a notable surge in revenue, peaking at approximately $8.8K in late November. Weekly downloads remained steady, hovering around the 600 to 700 range, while active users increased, reaching a peak of about 15.6K in early December.

Eko: Digital Stethoscopes showed a significant rise in revenue, peaking at about $7.9K just before the Christmas week. Downloads also saw a substantial increase, with a peak of 1.6K downloads in the week leading up to Christmas.

These insights are based on data from Sensor Tower, where more detailed analytics can be found. The quarter highlighted the varying dynamics and performance metrics across these leading medical applications in the US market.